✦ LIBER ✦

Prothrombin complex concentrate (Konyne) in the treatment of hemophilic patients with factor VIII inhibitors

✍ Scribed by Charles F. Abildgaard; Marcia Britton; Janet Harrison

Book ID: 118539527
Publisher: Elsevier Science
Year: 1976
Tongue: English
Weight: 441 KB
Volume: 88
Category: Article
ISSN: 1097-6833
DOI: 10.1016/s0022-3476(76)80982-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TREATMENT OF HEMOPHILIC PATIENTS WITH FA

TREATMENT OF HEMOPHILIC PATIENTS WITH FACTOR VIII INHIBITOR

✍ Charles F. Abildgaard; Marcia Britton 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

Multiple dental extractions with a new p

Multiple dental extractions with a new prothrombin complex concentrate in two patients with factor VIII inhibitors

✍ P.M Mannucci; A Federici; S Viganò; M Cattaneo 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 485 KB

The Role of Prothrombin Complex Concentr

The Role of Prothrombin Complex Concentrates In the Treatment of Hemophiliacs with Factor VIII Inhibitors

✍ Lusher, J. M. 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) ⚖ 539 KB

Acute myocardial infarction during treat

Acute myocardial infarction during treatment with an activated prothrombin complex concentrate in a patient with Factor VIII deficiency and a factor VIII inhibitor

✍ Stephen I. Chavin; David M. Siegel; Thomas A. Rocco Jr.; John P. Olson 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 560 KB

Clinical Efficacy of Prothrombin Complex

Clinical Efficacy of Prothrombin Complex Concentrates and Recombinant Factor VIIa in the Treatment of Bleeding Episodes in Patients with Factor VIII and IX Inhibitors

✍ Monika Barthels 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Activated prothrombin complex concentrat

Activated prothrombin complex concentrate (FEIBA®) treatment during surgery in patients with inhibitors to FVIII/IX

✍ G. E. Tjønnfjord; L. Brinch; T. Gedde-Dahl III; F. R. Brosstad 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

**Summary.** Non‐activated and activated prothrombin complex concentrates (PCC/aPCC) have been used successfully to treat bleeds in haemophilia patients with inhibitors, but most physicians do not consider these products as effective as factor VIII/IX (FVIII/IX) concentrates in non‐inhibitor patient